In ovarian cancer, IGF2BP1 enhances the phenotype of invasive tumour cells by antagonizing the expression of miRNA-impaired genes, and the increased expression of IGF2BP1 and most of the target mRNA regulated by its miRNA is related to poor prognosis and can promote tumour cells proliferation and metastasis [92]. This evidence concerns the gene IGF2BP1 and ovarian carcinoma.